Peritoneal Surface Malignancies Originating From Urachal Carcinoma: Case Reports and Review of the Literature

Urachal carcinoma (UC) is a rare and aggressive tumor arising from the urachal remnants, with the potential for peritoneal dissemination. Patients diagnosed with UC often have a poor prognosis. To date, there is no standardized treatment. Our objective is to present two cases of patients with peritoneal carcinomatosis (PC) secondary to an UC, who were treated with cytoreductive surgery (CRS) and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC). A review of the literature on CRS and HIPEC in UC suggests CRS and HIPEC to be a safe and viable treatment option. Two patients with PC of UC underwent CRS and HIPEC in our institution. All available data were gathered and reported on. A literary search was carried out to find all available cases of patients with PC secondary to UC treated with CRS and HIPEC. Both patients underwent CRS and HIPEC and are currently free of recurrence. Literature research revealed nine other publications adding up to a total of 68 additional cases. CRS and HIPEC can provide satisfactory long-term oncological outcome with acceptable morbidity and mortality rates in patients with PC of urachal origin. It should be considered as a safe and feasible treatment option with curative potential.

MO249SINGLE-CELL TRANSCRIPTOME OF COVID19 ASSOCIATED IGA NEPHROPATHY*

Background and Aims

Acute kidney injury is common in patients infected with the novel coronavirus SARS-CoV-2. Predominant findings in case series of kidney biopsies include acute tubular injury and collapsing podocytopathy. We performed single-cell RNA sequencing on kidney biopsy of a patient with COVID19-associated Henoch-Schönlein vasculitis, to investigate the underlying molecular changes.

Method

A 46-year-old woman presented with cutaneous vasculitis, arthritis, fever and microscopic hematuria. SARS-CoV-2 PCR on nasopharyngeal swab turned positive. Despite quick spontaneous resolution of symptoms, hematuria persisted and proteinuria increased in the next weeks. Subsequent kidney biopsy showed IgA nephropathy. Kidney biopsy was dissociated into a single-cell suspension and RNA was sequenced. 6126 kidney cells passed quality filters. Publicly available single cell sequencing data of 3 healthy kidney samples were integrated to allow comparison. The skin biopsy, performed at the initial presentation, was stained for the SARS-CoV-2 spike protein and the ACE2 protein using immunohistochemistry.

Results

Unsupervised clustering analysis of kidney identified 12 distinct cell types (Figure 1). T-lymphocytes were significantly enriched in COVID19 associated IgA nephropathy (16.7% versus 0.5%, 1.2% and 4.1% in healthy kidney, IgA nephropathy/healthy kidney ratio of relative % of T-/NK-cell clusters of 8.5), with a deviation towards CD8 lymphocytes and NK(T) cells (Figure 2). NK cells were solely present in IgA nephropathy compared to healthy kidney (1.5% versus 0% in all healthy kidneys).

Several genes involved in immune activation, oxidative stress and injury were upregulated in podocytes and mesangial cells. For example, one of the genes upregulated in podocytes was macrophage migration inhibitory factor (MIF) which is known to be involved in podocyte injury and mesangial sclerosis. In endothelial cells pathways involved in NK cell immunity, antigen presentation, interferon gamma signaling, and viral entry were upregulated. In T lymphocytes pathways of antigen presentation and T cell cytotoxicity were enriched.

In the skin biopsy, immunohistochemistry was positive for SARS-CoV-2 spike protein inside inflammatory cells, while the ACE2 receptor was positive in the same inflammatory cells, as well as inside endothelial cells.

Conclusion

Although both innate and adaptive immunity are considered to be involved in IgA nephropathy, our single cell sequencing data demonstrates that mainly T-lymphocytes, especially CD8 cells and NK cells, are enriched in COVID19 associated IgA nephropathy. Further elucidation of the involved pathways and the T cell receptor is planned. Interestingly, the SARS-CoV-2 virus could be identified inside the inflammatory cells in the skin in the context of cutaneous vasculitis, suggesting a direct pathologic effect.

Comprehensive targeted next-generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor

Mutational analysis guides therapeutic decision making in patients with advanced-stage gastrointestinal stromal tumors (GISTs). We evaluated three targeted next-generation sequencing (NGS) assays, consecutively used over 4 years in our laboratory for mutational analysis of 162 primary GISTs: Agilent GIST MASTR, Illumina TruSight 26 and an in-house developed 96 gene panels. In addition, we investigated the feasibility of a more comprehensive approach by adding targeted RNA sequencing (Archer FusionPlex, 11 genes) in an attempt to reduce the number of Wild Type GISTs. We found KIT or PDGFRA mutations in 149 out of 162 GISTs (92.0%). Challenging KIT exon 11 alterations were initially missed by different assays in seven GISTs and typically represented deletions at the KIT intron 10-exon 11 boundary or large insertions/deletions (>24 base pairs). Comprehensive analysis led to the additional identification of driver alterations in 8/162 GISTs (4.9%): apart from BRAF and SDHA mutations (one case each), we found five GISTs harboring somatic neurofibromatosis type 1 (NF1) alterations (3.1%) and one case with an in-frame TRIM4-BRAF fusion not reported in GIST before. Eventually, no driver alteration was found in two out of 162 GISTs (1.2%) and three samples (1.9%) failed analysis. Our study shows that a comprehensive targeted NGS approach is feasible for routine mutational analysis of GIST, thereby substantially reducing the number of Wild Type GISTs, and highlights the need to optimize assays for challenging KIT exon 11 alterations.

Glioblastoma with extracranial parotid, lymph node, and pulmonary metastases: a case report

We present a rare case of an isocitrate dehydrogenase-wildtype glioblastoma with histologically proven parotid, cervical lymph node, and lung metastases. While recent therapy advances are likely to increase glioblastoma mid- and long-term survival, this will also increase the time window for extraneural glioblastoma spread. Radiologists should be aware of this risk, so they can accurately detect and interpret metastatic glioblastoma disease.

Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis

OBJECTIVE

No therapy for non-alcoholic steatohepatitis (NASH) has been approved so far. Roux-en-y gastric bypass (RYGB) is emerging as a therapeutic option, although its effect on NASH and related hepatic molecular pathways is unclear from human studies. We studied the effect of RYGB on pre-existent NASH and hepatic mitochondrial dysfunction-a key player in NASH pathogenesis-in a novel diet-induced mouse model nicely mimicking human disease.

DESIGN

C57BL/6J mice were fed a high-fat high-sucrose diet (HF-HSD).

RESULTS

HF-HSD led to early obesity, insulin resistance and hypercholesterolaemia. HF-HSD consistently induced NASH (steatosis, hepatocyte ballooning and inflammation) with fibrosis already after 12-week feeding. NASH was accompanied by hepatic mitochondrial dysfunction, characterised by decreased mitochondrial respiratory chain (MRC) complex I and IV activity, ATP depletion, ultrastructural abnormalities, together with higher 4-hydroxynonenal (HNE) levels, increased uncoupling protein 2 (UCP2) and tumour necrosis factor-α (TNF-α) mRNA and free cholesterol accumulation. In our model of NASH and acquired mitochondrial dysfunction, RYGB induced sustained weight loss, improved insulin resistance and inhibited progression of NASH, with a marked reversal of fibrosis. In parallel, RYGB preserved hepatic MRC complex I activity, restored ATP levels, limited HNE production and decreased TNF-α mRNA.

CONCLUSIONS

Progression of NASH and NASH-related hepatic mitochondrial dysfunction can be prevented by RYGB. RYGB preserves respiratory chain complex activity, thereby restoring energy output, probably by limiting the amount of oxidative stress and TNF-α. These data suggest that modulation of hepatic mitochondrial function contributes to the favourable effect of RYBG on established NASH.

Development and external validation of new ultrasound-based mathematical models for preoperative prediction of high-risk endometrial cancer

OBJECTIVES

To develop and validate strategies, using new ultrasound-based mathematical models, for the prediction of high-risk endometrial cancer and compare them with strategies using previously developed models or the use of preoperative grading only.

METHODS

Women with endometrial cancer were prospectively examined using two-dimensional (2D) and three-dimensional (3D) gray-scale and color Doppler ultrasound imaging. More than 25 ultrasound, demographic and histological variables were analyzed. Two logistic regression models were developed: one 'objective' model using mainly objective variables; and one 'subjective' model including subjective variables (i.e. subjective impression of myometrial and cervical invasion, preoperative grade and demographic variables). The following strategies were validated: a one-step strategy using only preoperative grading and two-step strategies using preoperative grading as the first step and one of the new models, subjective assessment or previously developed models as a second step.

RESULTS

One-hundred and twenty-five patients were included in the development set and 211 were included in the validation set. The 'objective' model retained preoperative grade and minimal tumor-free myometrium as variables. The 'subjective' model retained preoperative grade and subjective assessment of myometrial invasion. On external validation, the performance of the new models was similar to that on the development set. Sensitivity for the two-step strategy with the 'objective' model was 78% (95% CI, 69-84%) at a cut-off of 0.50, 82% (95% CI, 74-88%) for the strategy with the 'subjective' model and 83% (95% CI, 75-88%) for that with subjective assessment. Specificity was 68% (95% CI, 58-77%), 72% (95% CI, 62-80%) and 71% (95% CI, 61-79%) respectively. The two-step strategies detected up to twice as many high-risk cases as preoperative grading only. The new models had a significantly higher sensitivity than did previously developed models, at the same specificity.

CONCLUSION

Two-step strategies with 'new' ultrasound-based models predict high-risk endometrial cancers with good accuracy and do this better than do previously developed models.

Imaging in gynaecological disease: clinical and ultrasound characteristics of mucocele of the appendix. A pictorial essay

The aim of this pictorial essay is to describe the ultrasound characteristics of the mucocele of the appendix (MA) by transvaginal ultrasound. The databases of the pathology and gynaecology departments of two Belgian hospitals were retrospectively searched for all cases of MA. Only patients who received a pre-operative transvaginal ultrasound scan by an experienced ultrasound examiner following the IOTA protocol were included. Ultrasound -characteristics were described and pattern recognition was applied in order to find morphological characteristics typical for MA. Thirty-one cases were found of which five underwent a transvaginal ultrasound. In three out of these five cases a mucocele was described. All three masses had a similar morphology, i.e. a para-ovarian uni-locular tubular mass with a color score of 1. A typical characteristic was the aspect of the cyst content, which resembled whipped cream. Although MA is seldom diagnosed by gynaecologists, transvaginal ultrasound is able to make an accurate diagnosis. MA is a -para-ovarian, unilocular tubular mass that typically has a cyst content that resembles whipped cream.

Ovarian cancer arising in endometrioid cysts: ultrasound findings

OBJECTIVES

To describe sonographic characteristics of malignant transformation in endometrioid cysts.

METHODS

Women with a histological diagnosis of ovarian endometrioid cysts, borderline tumors arising in endometrioid cysts and carcinoma arising in endometrioid cysts, preoperatively examined sonographically, were included in this retrospective study. Gray-scale and Doppler ultrasound characteristics of the endometrioid cysts were compared with those of the borderline tumors and primary cancers arising in endometrioid cysts. The performance of an experienced examiner in classifying the masses was also assessed.

RESULTS

Of 324 cases collected for the study, 309 (95.3%) lesions were classified as endometrioid cysts, four (1.2%) as borderline tumors arising in endometrioid cysts and 11 (3.4%) as carcinoma arising in endometrioid cysts. Women with malignant findings (borderline ovarian tumors and cancers) were older (median age 52 (range, 28-79) years) than those with benign endometrioid cysts (median age 34 (range, 18-76) years) (P<0.0001), and the prevalence of postmenopausal status was significantly higher in malignant cases. All (15/15) malignant tumors vs. 16% (50/309) of benign tumors were characterized by the presence of solid tissue (P<0.0001). The prevalence of solid tissue with positive Doppler signals was higher in malignant tumors (100%) than in benign cysts (7.8%) (P<0.0001). Papillary projections were a more frequent sonographic feature among malignant lesions (86.7%) than among benign endometrioid cysts (11.3%) (P<0.0001); power Doppler signals were detected within the projections in 92.3% and 37.1% of malignant and benign lesions, respectively. The examiner correctly diagnosed 94.8% (293/309) of benign lesions as benign and 93.3% (14/15) of malignant lesions as malignant. The risk estimation of the examiner was 'uncertain' in three (20%) and 'probably/certainly malignant' in 12 (80%) of 15 malignant cases.

CONCLUSION

Borderline tumors and carcinomas arising in endometrioid cysts show a vascularized solid component at ultrasound examination.